Two Chinese anti-SARS-CoV-2 drugs conditionally approved for marketing
Medical Xpress· 17 hours agoTwo Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir...
Chinese moviegoers — starved for entertainment and craving normalcy — are set to put the country’s...
MarketWatch· 5 days agoWhile global and domestic businesses eagerly await the return of Chinese consumer spending, one...
Researcher might have found key to understanding why COVID-19 kills more men than women
Medical Xpress· 6 days agoFrom the first months of the COVID-19 pandemic, observers noted that men are more susceptible to severe infections of the SARS-CoV-2 virus, with increased death rates.
Tricare Will Pay for More Dialysis Services Following COVID-Linked Rise in Kidney Disease
Military.com via Yahoo News· 7 days agoPatients with failing kidneys will have more care charges covered at dialysis clinics under a...
Rich Woller: The skepticism of scientists and science-deniers — and how education can close the gap
Berkshire Eagle· 5 hours agoThe couple thanked me for taking the time to explain virus, cell and COVID-19 vaccine biology to...
Millions of coronavirus mutations offer a new insight into evolution
New Scientist· 22 hours agoUsing publicly available SARS-CoV-2 sequences, researchers have revealed the genetic sites that must...
Two moms sue New York school district for ‘emotional distress’ caused by mask enforcement
Fox News· 6 days agoMonique Parsons and Jennifer Venth accused a New York school district of prompting “emotional...
Is COVID-19 a trigger for Lyme disease? Research and more
Medical News Today· 6 days agoLyme disease is an infection a person develops after a bite from a tick carrying certain bacteria....
A scientist is using AI to design a nasal spray that could protect us from the flu, COVID, and colds
Business Insider· 7 days agoA researcher is developing a nasal spray using custom proteins that could protect against COVID-19....
New reassessments of how clinical trials can and should be conducted
Medical Xpress· 5 days agoDuring his reign (605 BCE–562 BCE), Nebuchadnezzar II, King of Babylon, Sumer, Akkad and all of the...